This content has been produced by Opto and was originally published on the Opto Blog.
The share price of consumer goods giant Unilever [ULVR.L] has slumped over the past year and the company has come under criticism in recent months. Its restructuring and intense focus on environmental and social governance (ESG) credentials have failed to cheer investors so far.
Noted fund manager and owner of Fundsmith Terry Smith, who has been called the UK's Warren Buffett, published a scathing note on Unilever in January after the company failed to acquire GlaxoSmithKline's [GSK] consumer healthcare division.
Smith compared the acquisition offer a to "near death experience", adding the business Unilever would have sold if it bought GSK Consumer had outperformed the rest of the business.
"The investor pushback on the proposed GSK acquisition was ferocious, so I would rule out major M&A in the foreseeable future," Morningstar equity analyst Philip Gorham told Opto.
Ironically, with full-year 2021 sales growth at its highest in nine years and profits also rising, Unilever could be well placed to enact company-wide changes that may strengthen its position in the consumer goods market.
The Unilever share price has declined 15% in the past year to close at 3,455p on 31 March. This compares unfavourably with the broad-based rise in stock markets over the course of the year.
In fact, while the markets have picked up after the slump seen due to the Russia-Ukraine aggression a few weeks ago, the Unilever stock has remained inert. It is possible that the company's decision to cease operations in Russia could have some impact on its numbers.
The rise in commodity prices caused by the war in Ukraine could also affect its earnings. It has already highlighted cost inflation as a problem area in the past, which could get worse.
This, however, is just the challenge with its performance over the past year. In his note, Smith points out that Unilever's returns have been smaller than that of global multinationals like Procter & Gamble [PG] and Nestle [NESN] even over a longer time period.
"Unilever's problem is that it is in categories that are structurally weak: fragmented, competitive, with low pricing power and commodified products," Gorham said, adding that "the consumer is simply unwilling to pay more in these categories".
This does indicate that, despite the encouraging latest figures, the company could do with change. Activist hedge fund Trian Partners built up a stake in the company recently, sparking speculation that it might push a bit of a shakeup at Unilever.
Big changes are already visible. Earlier this year, the company decided to divide its business into five parts: beauty and wellbeing, personal care, home care, nutrition and ice cream. In its press release announcing the change in January, Unilever said that the move is "designed to continue the step-up we are seeing in the performance of our business".
More recently, according to a Financial Times report, Unilever has decided to publish the nutrition scores for its food portfolio against external health metrics. The decision, which was announced in March, was reportedly taken in response to investor pressure to combat obesity. The move was also supported by ShareAction, a charity that works with Unilever shareholders to drive positive change in areas like public health. Ignacio Vazquez, who works with the charity, said "the health profile of the food and drink products it sells remains a blind spot". This remark is in comparison with Unilever's otherwise strong focus on sustainability.
ESG is a growing area of focus for not just businesses but also investors and consumers. Unilever's focus in this area could create greater brand value for the already well-established multinational.
It may, however, be too much of a good thing, as Terry Smith said the company had expanded its ESG initiatives at the expense of profits.
The outlook on the Unilever share price is mixed. According to 12 analysts polled by MarketBeat, the stock has a consensus 'hold' rating and an average price target of 3,948.33p, representing a 14.3% upside on the 31 March closing price.
"Ideally, [Unilever] needs to move into stronger categories, where the consumer can be premiumised, as this would drive growth and margins," said Gorham.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.
The Home of Successful Investing.
© 2024 MyWallSt Ltd. All rights reserved.
Services
Social
Company
Support
This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.